Archive |
ProImmune leads in Antigen Discovery
REVEALä B Cell Epitope Discovery System
The REVEAL™ B Cell Epitope Discovery System perfectly complements our long standing strength in T cell research and allows us to offer a complete solution to our customers for antigen discovery and antigenicity testing
ProImmune Ltd, has launched the REVEAL™ B Cell Epitope Discovery System, a service designed to accelerate the development of biological therapies & understanding of diseases at a structural level.
The REVEAL™ service offers both comprehensive best consensus epitope prediction and rapid high throughput linear epitope mapping in vitro.
REVEAL™ consensus epitope prediction is a key tool in developing incisive hypotheses for downstream in vitro research. The service is based not only on primary sequence and 3D structure, but also incorporates any other additional information about the protein of interest from publicly available sources, and the experience and knowledge of ProImmune’s expert team to provide an intelligent consensus prediction to identify potential epitopes in a protein of interest.
Unlike hard to control assays that rely on recombinant or purified proteins, REVEAL™ linear epitope mapping relies on standardized peptide synthesis, which simplifies and accelerates the measurement of large numbers of samples. Based on ProArray™ high-content peptide microarrays that can include thousands of peptides, the service provides a turnkey solution for applications such as vaccine subunit discovery, immunogenicity testing, and correlating antibody responses to protein targets with disease onset, progression and outcome.
Dr. Nikolai Schwabe, CEO of ProImmune, said: “The REVEAL™ B Cell Epitope Discovery System perfectly complements our long standing strength in T cell research and allows us to offer a complete solution to our customers for antigen discovery and antigenicity testing.”
For more information, please contact
At ProImmune:
Dr Nikolai Schwabe, CEO
Tel: +44 (0) 870 042 7279
Email: enquiries@proimmune.com
Media enquiries:
College Hill
Lorna Cuddon, Kathryn Robertson, Jo Bowler
Tel: +44 (0)1260 296 506 / +44 (0)1260 296 505
Email: kathryn.robertson@collegehill.com
About ProImmune - www.proimmune.com
ProImmune is a private biotechnology company with its headquarters in Oxford, UK, that specializes in providing products and services for epitope discovery, immune monitoring and the design of biological drugs with reduced immunogenicity risk. ProImmune has a wide range of customers from leading pharmaceutical and biotechnology companies, as well as clinical and academic research institutes throughout the world.
